Infections of human papillomavirus (HPV) induce a variety of benign tumors, such as warts and condylomas. During the process of aberrant cell proliferation, genetic mutations are accumulated in the cells, from which malignant tumor cells arise. The viral oncoproteins E6 and E7 are known to help disrupt the cell cycle checkpoint machinery and accelerate chromosomal instability, events which are critical in malignant conversion. However, the mechanisms involved in the hyperplasia caused by HPV infection have remained unknown. We analysed the effects of regulatory genes of HPV18, a typical high-risk-type HPV, on the formation of the epithelial organ by using an organotypic culture system, and found that E7 had potent activity to induce hyperplasia, to which the disruption of the pRb pathway was well correlated. However, analysis with the E7 variants indicated that other pocket proteins are also involved in the activity.
Introduction
Human papillomavirus (HPV) is a small virus containing an approximately 8 kb double-stranded DNA genome (Howley and Lowy, 2001) . Human papillomavirus is a pathogenic virus, which infects basal layer cells in squamous epithelia and induces a variety of benign tumors. Human papillomaviruses are known to show tissue tropism, and are categorized as cutaneous or mucosal. The mucosal HPVs are grouped into high-and low-risk types in accordance with their relationship with cancers. The high-risk HPVs are associated with various mucosal epithelial cancers, such as cervical cancer and pharyngeal carcinoma. Most cervical cancers are associated with an HPV infection, which is therefore considered a major risk factor for cancer development (zur Hausen, 1996) . Although cutaneous HPVs are rarely associated with cancers, HPV5 and HPV8 can be classified into the high-risk group because of their relationship with the development of epidermodysplasia verruciformis, a rare skin tumor associated with inherent factors and immune-suppressive conditions (Majewski and Jablonska, 2003; Pfister, 2003) .
Human papillomavirus infections induce hyperproliferation, the development of dysplasia, immortalization, the accumulation of genetic mutations in cells and, eventually, malignant phenotypes. Thus, the tumorigenesis induced by HPV infections is an excellent model for multistage cancer development (Boutwell, 1989) . The viral oncoproteins E6 and E7 are mainly responsible for the accumulation of genetic mutations and immortalization (Mu¨nger et al., 2004) , given that (i) they bind to and inactivate p53 and pRb, respectively, which have important roles in cell cycle checkpoints (Dyson et al., 1989; Scheffner et al., 1990 Scheffner et al., , 1993 Huibregtse et al., 1991 Huibregtse et al., , 1993 ; (ii) they are reported to disrupt the processes for eliminating aberrant cells, including apoptosis and senescence (Pan and Griep, 1995; Helt et al., 2002; Iwasa et al., 2003) ; (iii) E7 is reported to actively promote chromosomal abnormality by inducing the aberrant duplication of centrosomes (Duensing et al., 2001a, b; Duensing and Mu¨nger, 2003) and (iv) E6 is critical in the immortalization of cells by reactivating hTERT expression, which abolishes the limitation on the cell's lifespan in corporation with the shutdown of the pRb pathway by E7 (Klingelhutz et al., 1996; Kiyono et al., 1998) . The importance of E6 and E7 in the development of cancer is also indicated by the finding that their expression is maintained in most HPVpositive cancers (Baker et al., 1987; Choo et al., 1987; Jeon and Lambert, 1995) and that the viability of cancerous cells is reduced by a suppression of their expression (Dowhanick et al., 1995; Desaintes et al., 1997; Nishimura et al., 2000) . Thus, these functions of E6 and E7 render the infected cells tolerant of various genetic mutations, and, consequently, some of the cells obtain malignant phenotypes, although the responsible cellular genes remain unknown.
The acceleration of cellular proliferation through inflammatory responses or organ regeneration is important in cancer development, because it promotes the accumulation of genetic alterations, creating large pools of variant cells, and thus allows cells having malignant properties to emerge. The hyperplasia induced by HPV infection is also considered responsible for the viral oncogenesis, although the molecular mechanism involved has not been fully understood. Here, we analysed the effects of regulatory genes of high-risk HPV on the formation of the epithelial organ by using an organotypic culture system (raft culture). The raft culture system can reproduce epithelial morphogenesis in vitro and is reported to support the HPV replication cycle (Dollard et al., 1992; Meyers et al., 1992; Frattini et al., 1996) , indicating that the system is suitable for the analysis of HPV gene function in hyperplasia. Among the regulatory genes studied here, E7 showed strong activity to induce hyperplasia. Although the involvement of E7 function in hyperplasia formation has already been described in several reports (Blanton et al., 1992; Halbert et al., 1992; Cheng et al., 1995) , the index for hyperplasia induction was mostly restricted to the expression of proliferative cell nuclear antigen (PCNA) in the suprabasal layer of epidermis. In contrast to them, our assay model could clearly recapture thickly developed hyperplasia, which makes it possible to analyse the mechanism for hyperplasia induction in detail. The analysis with the E7 variants revealed that multiple functions of E7, including the inactivation of pRb, contributed to the activity.
Results

Introduction of human papillomavirus regulatory genes in human keratinocytes
Human papillomavirus infection induces various benign hyperproliferative lesions at the infected locus. By using a raft culture system, keratinocytes containing high-risktype HPV DNA were reported to organize hyperplasialike structure (McCance et al., 1988; Steenbergen et al., 1998) , although the molecular mechanism(s) responsible for the hyperproliferation has not been fully understood. In order to identify the responsible factor(s), each of the regulatory genes of HPV18 was introduced into primary human foreskin keratinocytes (HFKs) using a retrovirus-mediated gene transfer, and their effects on cell proliferation were monitored. The growth potential and morphology of the control cells infected with the empty vector (LXSN) were similar to those of the mockinfected cells (data not shown), indicating that the gene transfer procedure did not affect the cellular properties. The growth potential of the cells expressing E6, E7 or both did not differ significantly from the control under the monolayer culture conditions (Figure 1 ). We observed reduced growth potential in the E4-expressing cells, which showed flattened and enlarged shapes, suggesting that the E4 expression induced G2/M cell cycle arrest (Davy et al., 2002; Nakahara et al., 2002) . With the morphological analysis, apoptotic cells appeared in the E5-expressing cell population, which resulted in a retardation of growth as observed with E4-expressing cells (Figure 1 ). Under the conditions of monolayer culture, the gene responsible for the HPVinduced hyperplasia could not be identified.
Potential of human papillomavirus regulatory genes to induce hyperplasia in the raft culture system Next, the effects of HPV regulatory genes on the epithelial morphogenesis were analysed by using a raft culture with the keratinocytes expressing the genes. There was no significant difference in the epithelial structure of the raft cultures constructed with the cells infected with the empty vector and the mock-infected cells (data not shown). Among the genes tested here, E7 expression induced a very strong hyperplasia as shown in Figure 2 . The E7-induced hyperplasia was reported with transgenic mouse model (Herber et al., 1996; Gulliver et al., 1997) , in which clearly thickened epidermal hyperplasia could be observed. Although the E7-mediated aberrant DNA synthesis in suprabasal layer of epidermis has been reported with raft culture system (Blanton et al., 1992; Halbert et al., 1992; Cheng et al., 1995) , those models could capture limited extent of hyperplasia found in the transgenic mouse model. Our assay system makes it possible to analyse the molecular mechanism for hyperplasia formation observed in mouse model under tissue culture condition.
Although E6 was reported to have a potential for hyperproliferation in mouse models (Song et al., 1999; Nguyen et al., 2003) , it had minimal effect on the epithelial structure in this assay. The function of E6 was confirmed by the analysis of p53 expression (Figure 3a and b), in which E6 could reduce the p53 protein level in both the monolayer and raft cultures. E7 significantly upregulated p53 expression, and such effect was counteracted in the cells expressing both E6 and E7, possibly as a result of E6/E6AP-mediated degradation of p53 (Scheffner et al., 1990 . The coexpression of E6 and E7 induced a hyperplasia in the raft culture similar to E7 expression, indicating that the modification of p53 level did not affect the hyperplasia formation.
E4 and E5 expression caused a significant reduction in the thickness of the epidermal layer in the raft culture (Figure 2 ), which could be considered a result of the growth-inhibitory effects by those genes as shown in Figure 1 .
Contribution of the inactivation of pRb to hyperplasia
The results described above indicated that the high-risk type E7 had strong activity to induce hyperplasia. It is Figure 2 Ability of the HPV regulatory genes to induce hyperplasia. The activity for hyperplasia was analysed with the organotypic raft culture. The HFKs expressing each HPV18 gene were used to construct the raft culture. The cryosection (7 mm) was fixed with 4% paraformaldehyde and stained with hematoxylin and eosin. Hyperplasia induction by HPV E7 T Ueno et al known that E7 interacts with pRb, one of the major tumor suppressor gene products, and inactivates it (Dyson et al., 1989) . With transgenic mouse model, the interaction between E7 and pRb was reported to be critical for induction of epidermal hyperplasia (Gulliver et al., 1997) . In order to investigate the relationship between the activities for inducing hyperplasia and inactivating pRb, the effects of a mutant HPV18 E7 (18E7) and a low-risk type E7, HPV11 E7 (11E7), on the formation of the epithelial structure were examined. An E7d24g mutant of 18E7 has a substitution at the adjacent amino acid to the binding motif to the pocket protein family, LXCXE (Dyson et al., 1992; Lee et al., 1998) . Aspartic acid and glycine at this position are unique to high-and low-risk E7s, respectively ( Figure 4a ). The d24g mutation, a substitution of aspartic acid at the position with glycine, converted the high-risk type 18E7 into a low-risk type (Heck et al., 1992) .
Each E7 was introduced into HFKs by retrovirusmediated gene transfer, and then the cells were analysed under the monolayer conditions. These E7s did not exhibit any significant effect on cell proliferation and morphology (data not shown). Wild-type 18E7 reduced the pRb protein level. In contrast, such activity was apparently diminished with E7d24g and 11E7 ( Figure 4a) .
Next, the raft culture system was constructed with the E7-expressing cells. Although the wild-type 18E7 showed strong activity to induce hyperplasia, such activity was significantly reduced with the mutant and low-risk E7s, suggesting that the inactivation of pRb was critical to the epithelial hyperproliferation ( Figure 4b ). The inhibitory effect of the wild-type 18E7 on pRb expression shown in Figure 4a could be observed also in the raft culture, and the mutant and low-risk type E7s lost such an effect. The epithelial hyperproliferation induced by pRb inactivation was reported previously with conditional gene disruption in mice (Balsitis et al., 2003) . Although the inactivation of pRb could be considered critical in the hyperplasia formation, there remained a possibility that some other activity of E7 was also involved, because the hyperplasia could be observed morphologically with the mutant and low-risk-type E7s, even though their effects were weak in comparison with the wild type. The hyperplasia induced by E7d24g and 11E7 was confirmed by the ectopic DNA synthesis in the upper layer of the epidermis (Figure 4b , BrdU).
Involvement of other pocket proteins in hyperplasia E7 is known to interact with other pocket proteins in addition to pRb, and 18E7 and 11E7 showed a similar binding affinity for p107 and p130 with in vitro binding experiments (data not shown). The effect of E7 on the expression of p107 and p130 was monitored with the monolayer cultures (Figure 5a ). Although the p107 expression was not modified, the p130 level was clearly reduced by 18E7. Interestingly, the inhibitory effect on p130 expression was also observed with E7d24g and 11E7. It was reported that p130 was associated with G0 exit of the cell division cycle and cellular differentiation process (Lipinski and Jacks, 1999; Classon and Dyson, 2001) . Consistent with the reports, the nuclear expression of p130 was upregulated as the basal cells moved up to the surface layer of the raft culture (Figure 5b , Cr). In contrast, the p130 level was apparently suppressed in the 18E7-expressing raft culture, expression of which could be detected only at the suprasurface. Such suppression was also observed with E7d24g and 11E7, indicating that the suppression of p130 expression by E7 might contribute to the hyperplasia formation by disturbing the differentiation program.
Effect of RNAi-mediated suppression of pocket protein expression on epithelial morphogenesis The results shown above indicate a possibility that the inactivation of both pRb and p130 by E7 is involved in the hyperplasia formation. However, we could not exclude the possibility that some other function of E7 might be a major responsible factor for the hyperplasia formation, because E7 is known to associate with a variety of cellular events other than the interaction with pocket proteins . To obtain direct evidence of the involvement of pRb and/or p130 in the hyperplasia formation, we employed RNAi-mediated gene suppression for the pocket proteins.
Three shRNAs were designed for each pocket protein, and those shRNA-expression retroviral vectors were introduced into HFKs. About half of the shRNAs could effectively suppress the pocket protein expression (Figure 6a ). The knockdown of pRb expression did not significantly affect the expression of p130, indicating that the suppression of p130 by E7 shown in Figure 5 was not a secondary effect of the downregulation of pRb. The suppression of pocket protein expression did not affect significantly the cell viability and morphology under the monolayer culture condition (data not shown). The effect of the suppression of pocket protein expression on epithelial morphogenesis was analysed by constructing the raft culture (Figure 6b ). The pRb suppression induced apparent hyperplasia and ectopic DNA synthesis in upper layer of epidermis. The p130 suppression also induced hyperplasia and ectopic DNA synthesis, even though its effect was relatively mild as compared with the pRb suppression. These results support the hypothesis that wild-type 18E7 induces hyperplasia mainly through the pRb inactivation and that E7d24g and 11E7 cause mild hyperplasia through p130 inactivation. Interestingly, the cells that introduced p107-shRNA displayed thinner epidermal layer and weaker DNA synthesis than the control (Figure 6b , p107-sh1), suggesting that p107 is involved in the growth potential of epithelial cells.
Discussion
The hyperproliferation induced by HPV infection is considered an essential process in the development of cancer. Wide varieties of mutant cells arise from the enlarged cell population, among which a cell having a malignant phenotype can be selected as cancerous. In this report, we proved that E7, one of the oncoproteins of HPV, had strong activity for hyperplasia by using the raft culture system, and indicated that the inactivation of pRb by E7 mainly contributed to that activity. It was also suggested that the downregulation of p130 expression and/or JNK activation were involved in the hyperplasia. Although there were several reports that described the E7-induced hyperplasia using raft culture system (Blanton et al., 1992; Halbert et al., 1992; Cheng et al., 1995) , the hyperplasia reported in those reports was moderate as compared with that observed by using transgenic mouse system (Herber et al., 1996; Gulliver et al., 1997; Balsitis et al., 2003) . Our assay system well captured the epidermal hyperplasia observed in the mouse model, and it allows to analyse the function of E7 in hyperplasia formation in detail. It is difficult to identify the key factor that determines the difference between our raft culture and the others, because the culture consists of many variable elements, including the condition of primary cells.
The association between pRb and E7 induces the degradation of pRb through ubiquitin-dependent proteolysis (Boyer et al., 1996; Jones and Mu¨nger, 1997; Gonzalez et al., 2001) , which causes the release of the activated form of E2Fs, resulting in an acceleration of the cell cycle (Chellappan et al., 1992) . However, as shown in Figure 1 , the E7 expression did not affect significantly the proliferation of the HFKs at lowpassage numbers under the monolayer culture conditions, while it induced an apparent hyperproliferation in the raft culture (Figure 2) . It is known that the viability of normal HFKs is reduced and the cells enter a replicative senescence at higher numbers of passages, under which conditions the E7 expression is able to suppress the growth arrest and the acceleration of the cell cycle by E7 becomes apparent. The normal keratinocytes of epithelium lose the potential to proliferate and enter the differentiation program when they leave the basal layer. The inactivation of pRb by E7 might allow the cells to retain their proliferative potential after leaving the basal layer, causing the hyperplastic structure in the raft culture. The involvement of pRb-E7 interaction in hyperplasia formation was also reported previously (Gulliver et al., 1997; Chien et al., 2000) . However, the pRb expression pattern was not correlated with the cellular proliferation in the raft culture of normal HFKs (Figure 4b , Cr), suggesting that the function of pRb in cell proliferation may not be critical to epithelial development. In addition to its regulatory effect on cell proliferation through its association with E2Fs, pRb is reported to have a role in the differentiation process, which is independent of E2Fs (Lipinski and Jacks, 1999; Ruzinova and Benezra, 2003) and the disruption of which by E7 might be a key mechanism behind the hyperplasia. The importance of pRb in the normal development of epithelium is indicated by a report that a conditional gene targeting experiment caused keratinocyte hyperproliferation in the epithelia of the mouse (Balsitis et al., 2003) . It will be necessary to investigate the regulatory mechanism of the growth and differentiation of epithelial cells mediated by pRb function.
The result that the wild-type 18E7 induced the strongest hyperplasia in the raft culture indicated the importance of pRb's inactivation in epithelial hyperplasia (Figure 4b) . However, the E7s in which such activity is attenuated, E7d24g and 11E7, still had significant activity to induce hyperplasia, indicating that some other activity of E7 is involved. This was supported by the observation in the report mentioned above, in which the E7-induced augmentation of hyperplasia was observed in pRb-deleted tissues (Balsitis et al., 2003) . The hyperplasia induction by low-risk-type E7 was previously reported (Cheng et al., 1995) , although there was a controversial paper . It is well recognized that E7 can associate with the other pocket proteins, p107 and p130. The latter is considered to play a role in the transition into the G0 phase of the cell cycle and the induction of cellular differentiation (Gran˜a et al., 1998; Lipinski and Jacks, 1999; Classon and Dyson, 2001; Classon and Harlow, 2002) . Consistent with this, p130 was detected in the nucleus in the differentiated layer in the raft culture with the normal HFKs. The results shown in this report that the wildtype E7 expression as well as the mutant and low-risk (BrdU) . Note that the results with RB-sh2 and p107-sh2 were similar to those with RB-sh1 and p107-sh1, respectively. The immunohistochemical samples were counterstained with hematoxylin.
Hyperplasia induction by HPV E7
T Ueno et al type E7s could suppress the p130 expression raised the possibility that the modulation of p130 function by E7 contributes to the aberrant differentiation and hyperplasia. The possibility was strengthened by the gene suppression experiments using shRNAs (Figure 6 ), in which the involvement of pRb and p130 in the epidermal organization could be observed in the raft culture.
The action mechanism of E7 in the hyperplasia found in this report is illustrated in Figure 7 . While E7 expression accelerates the cell cycle through the inactivation of pRb, it inhibits the induction of differentiation through downregulation of p130, making the cells replicative and undifferentiated in the upper layer of the epidermis. It may be worth of note that the downregulation of p107 reduced the potential of cell proliferation at the basal cell layer. Taking into account the fact that E7 affects the expressions of pRb and p130 but not of p107 seems to be rational, because the DNA synthesis potential of the epithelial cells should be maintained for the HPV replication. Although p107 has been known to interact with the inhibitory E2Fs, E2F4 and E2F5, its role in cell proliferation and differentiation remains unclear. Our model system might reveal a novel biological activity of p107. Our result indicates that 18E7 could suppress the expression of pRb and p130, but not of p107. In contrast, reported that 16E7 inhibited the expression of all pocket proteins. Although we did not investigate the factor(s) involved in this discrepancy, it might result from the difference of the cells used in the experiments. Recently, reported the effect of high-and low-risk HPV E7 on the expression of pRb family member, the result shown in which is consistent with ours with regard to low-risk E7 (Zhang et al., 2005) .
It has been reported that many cellular factors interact with E7 and that some pRb-independent function of E7 is associated with the transformation activity . E7 is known to associate with p21 and p27 independently of the E7-pocket protein interaction, which might modulate the cell proliferation and differentiation program. It was also indicated previously that E7 expression modified the downstream pathway of the TNFa receptor (TNFR) in HFKs and a human fibroblast cell line Thompsom et al., 2001) , which is critical in the regulation of cell proliferation and apoptosis through the modification of NFkB activity and the activation of MAPKs, including JNK. With regard to the epidermal hyperplasia, there was a report that the activation of JNK in RelA À/À epidermis of mouse was causative for the hyperproliferation of keratinocytes (Zhang et al., 2004) . We have a preliminary result that 18E7 expression suppresses NFkB signaling upon the activation of TNFR pathway, suggesting a possibility that the E7 expression causes similar effect on epidermal organization, as observed with RelA knockout mice. It is necessary to take into account the various biological activities of E7 for full understanding of the mechanisms of the E7-mediated hyperplasia formation.
This report indicates the possibility that E7 is critical to the hyperplasia in HPV-infected lesions. The result showed that the high-risk-type E7 had stronger potential to induce hyperplasia than the low-risk-type E7 and the difference might be ascribable to their activities to inactivate pRb. However, it is considered that the hyperplasia by the low-risk HPV infection is more severe than that caused by the high-risk type, as seen in condylomas and warts, suggesting that the HPVinduced hyperplasia is mediated also by other gene functions. E6 was reported to activate the proliferation of epithelial cells, for which the PDZ-binding motif at the C-terminus was critical (Nguyen et al., 2003) . Although some aberrant DNA synthesis could be observed with the E6-expressing raft culture (data not shown), the E6 expression did not significantly induce hyperplasia as shown in Figure 2 , indicating that the contribution of E6 to the hyperplasia might be trivial. E5 is a major transforming gene in the bovine papillomavirus, which activates cellular proliferation by inducing PDGF receptor and/or EGF receptor activation (Howley and Lowy, 2001) . As shown in Figure 1 , 18E5 induced an apoptotic response in the cells, resulting in the suppression of cell viability. The activity was, however, cell-type dependent; 18E5 occasionally induced senescence-like growth arrest with other cell types (data not shown), indicating that the cellular protective response might be triggered for escaping from the aberrant stimulus induced by E5. Recently, hyperplasia induction by HPV16 E5 was reported with transgenic mouse model (Genther Williams et al., 2005) , indicating a possibility that such activity of E5 can be reproduced with the raft culture system. On co-expression with E6 or E7, the growth acceleration by E5 might become evident by avoiding apoptosis and senescence. The assay system used in this report seems to be suitable for analysis of HPV-induced hyperplasia in depth, and it will be interesting to analyse the effects of various combinations of HPV genes on hyperplasia.
Materials and methods
Construction of plasmid DNAs
DNA fragments containing each regulatory gene of HPV18 were isolated by a polymerase chain reaction (PCR) with a full-length HPV18 clone (GenBank Accession number X05015) as the template, and then transferred into the vector pLXSN (BD Biosciences Clontech, Palo Alto, CA, USA). The E7 gene of HPV11 (11E7) was also obtained by PCR with a full-length HPV11 clone (GenBank, M14119). The mutation d24g, designed to substitute a codon for aspartic acid (GAC) with that for glycine (GGG) at position 24 in 18E7, was introduced by PCR-mediated site-directed mutagenesis (Cormack, 1987) . At the 5 0 -terminus of each gene, a Kazak consensus sequence was introduced by PCR to optimize translation efficiency. The retroviral packaging plasmid, pCL10A1 (IMGENEX Corp., San Diego, CA, USA), and green fluorescence protein (GFP)-expression plasmid, pGreenLantern-1 (Invitrogen Corp., Carlsbad, CA, USA), were obtained commercially.
Cell culture and transfection
Human foreskin fibroblasts (HFFs) and HFKs were purchased commercially (KURABO Industries, Ltd, Osaka, Japan). 293T cells and HFFs were maintained with Dulbecco'smodified MEM (DMEM) supplemented with 10% fetal bovine serum (FBS), and HFKs were maintained with serum-free keratinocyte growth medium (KGM) (EpiLife-KG2, KUR-ABO Industries, Ltd, Osaka, Japan) in 5% CO 2 at 371C. 293T cells were transfected by a standard CaPO 4 co-precipitation method (Sambrool et al., 1989b) . The transfection efficiency was monitored using GFP, which was expressed from the cotransfected GFP-expression plasmid, pGreenLantern-1.
Production and infection of retroviral vector
The pLXSN-based gene expression plasmid (3.5 mg), pCL10A1 (1 mg), pGreenLantern-1 (0.5 mg) and herring sperm DNA (5 mg) were introduced into 293T cells by transfection. At 2 days after the transfection, the culture medium was replaced with fresh KGM and the retroviral vector was collected in the medium for 5 h (hrs). The vector-containing KGM was clarified through a 0.45-mm-pore filter and used to infect the HFKs. For the infection, the old KGM was removed and the virus-containing KGM was overlaid on the HFKs. The cells were maintained for 6 h in CO 2 incubator, and then the medium was changed to fresh KGM. At 24 h after infection, the cells were spread at a low density. G418 (80 mg/ml) was added to the medium at 48 h after infection for 2 days, after which the cells were maintained in 40 mg/ml G418/KGM. Using this selection procedure, the mock-infected cells were eliminated at 4 days post-infection. Usually, the multiplicity of infection was more than one.
Organotypic raft culture system The organotypic raft culture system was constructed as described previously (Tsunenaga et al., 1994) . For preparation of the dermal equivalent, one part of type I collagen (Cell Matrix type I-P, Nitta Gelatin Co. Ltd, Osaka, Japan) and two parts of growth medium containing HFFs (1 Â 10 6 cells) were mixed, while cooling, poured into a 6-cm dish, and then the cells were maintained in 5% CO 2 incubator at 371C until the collagen gel became contracted to 2 cm diameter. The gel was soaked in fresh KGM for several hours, and then transferred in a trans-well insert (Becton Dickinson Labware, Franklin Lakes, NJ, USA). The insert was put in a 6-well plate (Becton Dickinson Labware, Franklin Lakes, NJ, USA), and fresh KGM was filled both in the bottom and insert. Human foreskin keratinocytes (1 Â 10 6 cells) were overlaid on the gel (day 0). At day 1, the medium was changed to a mixture of KGM and DMEM growth medium (KGM:DMEM ¼ 1:1), and 24 h later the medium was changed to the same mixture, adjusting the CaCl 2 concentration to 1.8 mM. At day 3, the surface of the collagen gel was exposed to air, and then the medium in the bottom was changed to fresh medium every day. Multilayered cultures of keratinocytes were obtained at day 10. For BrdU incorporation, 50 mg/ml BrdU (SigmaAldrich Co., St Louis, MO, USA) was added in the medium 6 h before harvest.
Immunoblot analysis
Total cell lysate of HFKs was obtained with a triple-detergent buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.02% sodium azide, 0.1% sodium dodecylsulfate (SDS), 1% Nonidet P-40, 0.5% sodium deoxycholate (Sambrool et al., 1989a) supplemented with a protease inhibitor cocktail (0.5 mM PMSF, 0.15 mM aprotinin, 1 mM E-64, 1 mM leupeptin, 0.5 mM EDTA) (Nakarai Tesuque KK, Kyoto, Japan) and 1 mM dithiothreitol. Equal amounts of cell lysate (5 mg protein) were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and the gel was blotted to a PVDF membrane (Hypond-P, Amersham Biosciences UK Limited, Little Chalfont, UK). The equalities of the loaded amounts were confirmed with the anti-b-actin immunoblot (clone AC-15) (Sigma-Aldrich Co., St Louis, CO, USA) (data not shown). Horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham Biosciences UK Limited, Little Chalfont, UK) and a luminal reagent (Western Blotting Luminol Reagent, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were purchased commercially.
Immunohistochemical analysis
The specimens of raft culture were embedded in OCT compound (Sakura Finetechnical Co., Ltd, Tokyo, Japan), and thin sections (7 mm) were obtained by cryo-sectioning (Cryo-Star HM560M, MICROM Laborgera¨te GmbH, Walldorf, Germany). The sections were transferred onto slide glasses, dried, fixed with 4% paraformaldehyde, and then treated with the target retrieval solution (Target Retrieval Solution, Dako Japan KK, Kyoto, Japan). The endogenous peroxidase activity was quenched with 0.3% H 2 O 2 /MeOH after the target retrieval process. Antigen detection was performed with the TSA-biotin system (Perkin-Elmer, Boston, MA, USA) following the manufacturer's instructions. Chromogenic detection of HRP was performed with metalenhanced diaminobenzidine (DAB) substrate (Roche Diagnostics GmbH, Mannheim, Germany). Antibodies for p53 (Ab-6) (Oncogene Research Products, San Diego, CA, USA), pRb (BD Biosciences Pharmingen, San Diego, CA, USA), BrdU (clone 2B-1)(MBL, Nagoya, Japan), P107 (C-18), p130 (C-20) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were purchased commercially. The HRP-conjugated secondary antibodies were also commercially available (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).
RNAi-mediated gene suppression
The designed sequences of shRNA for the pocket proteins are the following. pRb-sh1: GAT ACT AGA TCG TGT CAG ATT CAA GAG ATC TGA CAT GAT CTG GTA TCT TTT TTA TCG AT; pRb-sh2: GTT GAT AAT GCT ATG TCA ATT CAA GAG ATT GAC ATA GCA TTA TCA ACT TTT TTA TCG AT; pRb-sh3: GGT TCG ACT ACG TGT GTA ATT CAA GAG ATT ACA CGC GTA GTT GAA CCT TTT TTA TCG AT; p107-sh1: ATC GTT CCT TCT TCG AGC ATT CAA GAG ATG CTT GAA GAA GGA GCG ATT TTT TTA TCG AT; p107-sh2: AGG GTG TCA TGG AGG GCA ATT CAA GAG ATT GCC TTC CAT GAT ACC CTT TTT TTA TCG AT; p107-sh3: GGG GGT CTT CGA GGA GAT ATT CAA GAG ATA TCT CTT CGA AGA CTC CCT TTT TTA TCG AT; p130-sh1: GCC AGC GGT AGT AAT GGA CCT TCA AGA GAG GTC TAT TAC TAC TGC  TGG CTT TTT TAT CGA T; p130-sh2: ATA CCC TCG  AGA GGG GCA ATT CAA GAG ATT GCT CCT CTT  GAG GGT ATT TTT TTA TCG AT; p130-sh3: GGT TCG  ACA ACG TGT GTA ATT CAA GAG ATT ACA CGC  GTA GTT GAA CCT TTT TTA TCG AT. For each shRNA, top and bottom oligonucleotides were synthesized and the annealed oligonucleotides were inserted into pSIREN-RetroQ vector by following the manufacturer's protocol (BD Biosciences Clontech, Palo Alto, CA, USA). The shRNAexpressing retrovirus vectors were produced as described in the section Production and infection of retroviral vector.
